Evidence map›Paper›PMID 38707629›Full record

ArticlePhysics and imaging in radiation oncology2024

Deep learning based automatic segmentation of the Internal Pudendal Artery in definitive radiotherapy treatment planning of localized prostate cancer.

Anjali Balagopal, Michael Dohopolski, Young Suk Kwon, Steven Montalvo, Howard Morgan, Ti Bai, Dan Nguyen, Xiao Liang, Xinran Zhong, Mu-Han Lin and 2 more

Abstract read
In one paragraph

Article in Physics and imaging in radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anjali BalagopalMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Michael DohopolskiMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Young Suk KwonMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Steven MontalvoMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Howard MorganMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Ti BaiMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Dan NguyenMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Xiao LiangMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Xinran ZhongMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Mu-Han LinMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Neil DesaiMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Steve JiangMedical Artificial Intelligence and Automation (MAIA) Laboratory and Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: Radiation-induced erectile dysfunction (RiED) commonly affects prostate cancer patients, prompting clinical trials across institutions to explore dose-sparing to internal-pudendal-arteries (IPA) for preserving sexual potency. IPA, challenging to segment, isn't conventionally considered an organ-at-risk (OAR). This study proposes a deep learning (DL) auto-segmentation model for IPA, using Computed Tomography (CT) and Magnetic Resonance Imaging (MRI) or CT alone to accommodate varied clinical practices. Materials and methods: A total of 86 patients with CT and MRI images and noisy IPA labels were recruited in this study. We split the data into 42/14/30 for model training, testing, and a clinical observer study, respectively. There were three major innovations in this model: 1) we designed an architecture with squeeze-and-excite blocks and modality attention for effective feature extraction and production of accurate segmentation, 2) a novel loss function was used for training the model effectively with noisy labels, and 3) modality dropout strategy was used for making the model capable of segmentation in the absence of MRI. Results: Test dataset metrics were DSC 61.71 ± 7.7 %, ASD 2.5 ± .87 mm, and HD95 7.0 ± 2.3 mm. AI segmented contours showed dosimetric similarity to expert physician's contours. Observer study indicated higher scores for AI contours (mean = 3.7) compared to inexperienced physicians' contours (mean = 3.1). Inexperienced physicians improved scores to 3.7 when starting with AI contours. Conclusion: The proposed model achieved good quality IPA contours to improve uniformity of segmentation and to facilitate introduction of standardized IPA segmentation into clinical trials and practice.

Indexed as

Automatic SegmentationDeep learningErectile DysfunctionInternal Pudendal Artery (IPA)Prostate cancer

Identifiers

PMID38707629
PMCPMC11068618

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.